|Description:||The indication to give Naloxone to reverse respiratory and central nervous system depression in a neonate following maternal opioid use during labour has been removed. There is little evidence to support its use in neonates. If Naloxone is given to neonates born to opioid addicted mothers there are concerns that it may produce withdrawal effects. Emphasis should be on effective drying and stimulation of the baby, systematic airway management with bag valve-mask ventilation and maintaining newborn temperature between 36.50C to 37.50C. Where these interventions do not achieve established respiratory effort the newborn should be rapidly conveyed to the nearest Emergency Department with an Obstetric Unit attached. The pre-alert should detail the neonatal emergency. The newborn should be conveyed, where necessary, ahead of the mother.|
|Date Update Posted Online:||September 7, 2017|
|Section Title:||Naloxone Hydrochloride (Narcan)|
|Guidelines Print Date:||September 20, 2017|
Guest Blog: Harnessing the Power of Front-Line Ambulance Staff – Reflections on the Launch of #ProjectA
Ian Baines, Transformation Consultant at NHS Horizons, reflects on an intense and rewarding kick-off for the...
What is good ambulance service care? Innovative new research animation explains why we need to look beyond response times
An innovative animation produced by researchers and patients highlights the problem with time targets...